Clinical trial NCT00608621 - References

Pain — Influence of Physostigmine on Patient-Controlled Analgesia (PCA) in Postoperative Intensive Care Patients

Citation(s)

•   Aiello-Malmberg P, Bartolini A, Bartolini R, Galli A
  Effects of morphine, physostigmine and raphe nuclei stimulation on 5-hydroxytryptamine release from the cerebral cortex of the cat. Br J Pharmacol. 1979 Apr;65(4):547-55.
•   Beilin B, Bessler H, Papismedov L, Weinstock M, Shavit Y
  Continuous physostigmine combined with morphine-based patient-controlled analgesia in the postoperative period. Acta Anaesthesiol Scand. 2005 Jan;49(1):78-84.
•   Passchier J, Rupreht J, Koenders ME, Olree M, Luitwieler RL, Bonke B
  Patient-controlled analgesia (PCA) leads to more postoperative pain relief, but also to more fatigue and less vigour. Acta Anaesthesiol Scand. 1993 Oct;37(7):659-63.
•   Röhm KD, Riechmann J, Boldt J, Schöllhorn T, Piper SN
  Do patients profit from physostigmine in recovery from desflurane anaesthesia? Acta Anaesthesiol Scand. 2007 Mar;51(3):278-83. Epub 2007 Jan 23.
•   Rupreht J, Schneck HJ, Dworacek B
  [Physostigmine--recent pharmacologic data and their significance for practical use]. Anaesthesiol Reanim. 1989;14(4):235-41. Review. German.

Influence of Physostigmine on Patient-Controlled Analgesia (PCA) in Postoperative Intensive Care Patients, Considering Pain Score, Opioid Consumption, Hemodynamics and Cognitive Function

Details for clinical trial NCT00608621